Chunfu Wang

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

Min Gao, Nicholas A. Meanwell, Lawrence G. Hamann, 2010, Nature.

Distinct Functions of NS5A in Hepatitis C Virus RNA Replication Uncovered by Studies with the NS5A Inhibitor BMS-790052

M. Gao, R. Fridell, Chunfu Wang, 2011, Journal of Virology.

Characterizations of HCV NS5A replication complex inhibitors.

N. Meanwell, D. Langley, J. Lemm, 2013, Virology.

The oncogenic potential of hepatitis C virus NS5A sequence variants is associated with PKR regulation.

M. Giménez-Barcons, J. Sánchez-Tapias, J. Saiz, 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Viral Evolution and Interferon Resistance of Hepatitis C Virus RNA Replication in a Cell Culture Model

M. Gale, R. Sumpter, Y. Loo, 2004, Journal of Virology.

Discovery and development of hepatitis C virus NS5A replication complex inhibitors.

N. Meanwell, D. Langley, J. Lemm, 2014, Journal of medicinal chemistry.

Entecavir Exhibits Inhibitory Activity against Human Immunodeficiency Virus under Conditions of Reduced Viral Challenge

N. Parkin, M. Krystal, R. Colonno, 2008, Antimicrobial Agents and Chemotherapy.

Alpha Interferon Induces Distinct Translational Control Programs To Suppress Hepatitis C Virus RNA Replication

M. Gale, R. Sumpter, G. Sen, 2003, Journal of Virology.

In Vitro Activity of Daclatasvir on Hepatitis C Virus Genotype 3 NS5A

Lingling Jia, M. Gao, R. Fridell, 2012, Antimicrobial Agents and Chemotherapy.

Liver X receptor (cid:2) induces 17 (cid:3) -hydroxysteroid dehydrogenase-13 expression through SREBP-1c

X. Ruan, Chunfu Wang, Yu-bing Dai, 2017 .